ArriVent BioPharma (AVBP) Shares Issued (2023 - 2026)
ArriVent BioPharma (AVBP) posted Shares Issued of $2.0 million for Q1 2026, down 54.1% sequentially from $4.3 million in Q4 2025, and down 51.05% YoY from $4.1 million in Q1 2025.
ArriVent BioPharma (AVBP) Shares Issued (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Shares Issued for 4 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Shares Issued fell 51.05% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 51.05% YoY) and the FY2025 annual result came in at $4.3 million, up 71.02% from the prior year.
- Shares Issued eased to $2.0 million in Q1 2026 per AVBP's latest filing, from $4.3 million in the prior quarter.
- Over five years, Shares Issued peaked at $4.4 million in Q3 2025 and troughed at $564452.0 in Q1 2024.
- A 4-year average of $2.5 million and a median of $2.3 million in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2025 and 2026: Shares Issued surged 619.16% in 2025, then sank 51.05% in 2026.
- Over 4 years, Shares Issued stood at $1.7 million in 2023, then surged by 50.38% to $2.5 million in 2024, then jumped by 71.02% to $4.3 million in 2025, then tumbled by 54.1% to $2.0 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $2.0 million, $4.3 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | 7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.30 Mn |
| Jun 30, 2026 | 7.30 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 4.06 Mn |
| Mar 31, 2025 | 4.06 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 646,440.00 |
| Jun 30, 2024 | 646,440.00 |
| Mar 31, 2024 | 564,452.00 |
| Mar 31, 2024 | 564,452.00 |